Our favorites come from FoodSaver, Anova, and Nesco.
Gout is often called refractory as newly dissolved urate deposits produce recurring flares, but one expert questioned the ...
Despite being in the earliest stages of clinical research, the makers of the novel drug NovoBioJect are touting results from ...
Eye bank specialists argue that the global corneal transplant shortage is as much a problem of tissue utilization, ...
A single-case report from Beirut describes six days of continuous antegrade liposomal amphotericin B irrigation through a ...
Week 12 clinical remission of 23.1% (3/13) in higher-dose Cohort 2 vs. 11.4% (4/35) in lower-dose Cohort 138.9% ...
The European Parliament has given the go-ahead for the update of the heat- and fuel-based ETS benchmarks for the period 2026–2030 ...
Conclusion of this article: 3 key points High stability in financial indicators: Equity ratio of 70.4%, with approximately 17 ...
Legend Biotech's Q2 shows CARVYKTI sales hitting $710M and improving operating leverage. Find out why LEGN stock is a buy.
Research and Development Investment increased by 16.1% YoY to RMB 785.1 million for the 9 months ended September 30, 2026, reflecting the advancement of additional Phase III clinical trials, as well ...
Aside from RG6540, Roche also discontinued a host of other early-stage assets, including an antisense oligonucleotide for ...
A takeover headline can read like free money, which is exactly when it deserves the hardest look. Consider Vesuvius, a ...